Entries by Samantha Petersen

Balancing the books for cross-border M&A in India

Statista recently reported that India has become an attractive mergers and acquisitions (M&A) market. The data platform projects that M&A transaction value in this region will reach US$44.86 billion in 2025, with the average transaction amounting to US$105.52 million.

Translink Corporate Finance advised the minority shareholders in Aas Mek Verksted AS on the sale of their shares to the majority owners

Translink Corporate Finance in Norway acted as the advisor to the minority shareholders in Aas Mek Verksted AS, who have opted to sell their shares to the majority owners, streamlining ownership within the company. With this transaction, Aas Mek Verksted AS reinforces its long-term vision under consolidated ownership, ensuring continuity in its shipbuilding operations.

Healthcare M&A report uncovers how strategic dealmaking is driving innovation & growth

The healthcare sector remains one of the most active in terms of mergers and acquisitions (M&A), demonstrating resilience and strategic innovation even in the face of evolving market conditions. According to the latest Translink Corporate Finance M&A Healthcare Insights report, 2024 continued to see robust transaction activity, despite a slight decline in deal volumes compared to the previous year.

Translink’s US partner, Dinan & Company, initiated the acquisition of Maskwa High Voltage by ENTRUST Solutions Group, a portfolio company of Kohlberg & Company, LLC

Translink Corporate Finance in the United States, Dinan & Company, initiated the acquisition of Maskwa High Voltage LTD by ENTRUST Solutions Group, which is majority-owned by Kohlberg & Company, a leading private equity firm based in Mount Kisco, NY, with additional minority investment from Neuberger Berman Alternatives, a private, independent, employee-owned investment manager.

Translink Corporate Finance advised Institut für histologische und zytologische Diagnostik AG Aarau on the sale to Affidea Group

Translink Corporate Finance Switzerland advised Institut für histologische und zytologische Diagnostik AG Aarau on the sale to Affidea Group (Affidea). This acquisition adds two high-quality pathology laboratories – one in Zollikon next to Zürich, close to Affidea’s Centre of Excellence in Breast Cancer, Brust-Zentrum Zurich, and another one in Aarau, Argovia.